Advertisement

Reactions Weekly

, Volume 1719, Issue 1, pp 100–100 | Cite as

Ferric-carboxymaltose

Hypophosphataemic osteomalacia: case report
Case report

Reference

  1. Klein K, et al. Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration. BMJ Case Reports 2018: 3 Jan 2018. Available from: URL: http://doi.org/10.1136/bcr-2017-222851 - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations